8-OH-DPAT
| Names | |
|---|---|
| Systematic IUPAC name
7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol | |
| Identifiers | |
3D model (JSmol) |
|
| Abbreviations | 8-OH-DPAT |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| MeSH | 8-Hydroxy-2-(di-n-propylamino)tetralin |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C16H25NO | |
| Molar mass | 247.382 g·mol−1 |
| log P | 3.711 |
| Acidity (pKa) | 10.539 |
| Basicity (pKb) | 3.458 |
| Pharmacology | |
| Pharmacokinetics: | |
| 1.5 hours | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
8-OH-DPAT is a research chemical of the aminotetralin chemical class which was developed in the 1980s and has been widely used to study the function of the 5-HT1A receptor. It was one of the first major 5-HT1A receptor full agonists to have been discovered.
Originally believed to be selective for the 5-HT1A receptor, 8-OH-DPAT was later found to act as a 5-HT7 receptor agonist and serotonin reuptake inhibitor/releasing agent as well.
In animal studies, 8-OH-DPAT has been shown to possess antidepressant, anxiolytic, serenic, anorectic, antiemetic, hypothermic, hypotensive, bradycardic, hyperventilative, and analgesic effects.